These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. A Series of New Hydrazone Derivatives: Synthesis, Molecular Docking and Anticholinesterase Activity Studies. Bozbey İ; Özdemir Z; Uslu H; Özçelik AB; Şenol FS; Orhan İE; Uysal M Mini Rev Med Chem; 2020; 20(11):1042-1060. PubMed ID: 31660824 [TBL] [Abstract][Full Text] [Related]
28. Synthesis, characterization, evaluation of metabolic enzyme inhibitors and in silico studies of thymol based 2-amino thiol and sulfonic acid compounds. Bora RE; Genc Bilgicli H; Üç EM; Alagöz MA; Zengin M; Gulcin İ Chem Biol Interact; 2022 Oct; 366():110134. PubMed ID: 36057360 [TBL] [Abstract][Full Text] [Related]
29. 1,2,3-Triazole substituted phthalocyanine metal complexes as potential inhibitors for anticholinesterase and antidiabetic enzymes with molecular docking studies. Koçyiğit ÜM; Taslimi P; Tüzün B; Yakan H; Muğlu H; Güzel E J Biomol Struct Dyn; 2022 Jul; 40(10):4429-4439. PubMed ID: 33292060 [TBL] [Abstract][Full Text] [Related]
30. Synthesis, biochemical and computational evaluations of novel bis-acylhydrazones of 2,2'-(1,1'-biphenyl)-4,4'-diylbis(oxy))di(acetohydrazide) as dual cholinesterase inhibitors. Ibrahim M; Halim SA; Latif A; Ahmad M; Ali S; Ullah S; Khalid A; Abdalla AN; Khan A; Al-Harrasi A; Ali M Bioorg Chem; 2024 Mar; 144():107144. PubMed ID: 38281382 [TBL] [Abstract][Full Text] [Related]
31. Bioactive sulfonyl hydrazones with alkyl derivative: Characterization, ADME properties, molecular docking studies and investigation of inhibition on choline esterase enzymes for the diagnosis of Alzheimer's disease. Bilen E; Özdemir Özmen Ü; Çete S; Alyar S; Yaşar A Chem Biol Interact; 2022 Jun; 360():109956. PubMed ID: 35452634 [TBL] [Abstract][Full Text] [Related]
32. Novel inhibitors with sulfamethazine backbone: synthesis and biological study of multi-target cholinesterases and α-glucosidase inhibitors. Türkeş C; Akocak S; Işık M; Lolak N; Taslimi P; Durgun M; Gülçin İ; Budak Y; Beydemir Ş J Biomol Struct Dyn; 2022; 40(19):8752-8764. PubMed ID: 33950796 [TBL] [Abstract][Full Text] [Related]
33. In-silico identification of the binding mode of synthesized adamantyl derivatives inside cholinesterase enzymes. Al-Aboudi A; Al-Qawasmeh RA; Shahwan A; Mahmood U; Khalid A; Ul-Haq Z Acta Pharmacol Sin; 2015 Jul; 36(7):879-86. PubMed ID: 25937631 [TBL] [Abstract][Full Text] [Related]
34. Novel tribenzylaminobenzolsulphonylimine based on their pyrazine and pyridazines: Synthesis, characterization, antidiabetic, anticancer, anticholinergic, and molecular docking studies. Mamedova G; Mahmudova A; Mamedov S; Erden Y; Taslimi P; Tüzün B; Tas R; Farzaliyev V; Sujayev A; Alwasel SH; Gulçin İ Bioorg Chem; 2019 Dec; 93():103313. PubMed ID: 31586711 [TBL] [Abstract][Full Text] [Related]
35. Synthesis, structural characterization, docking, lipophilicity and cytotoxicity of 1-[(1R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]-3-alkyl carbamates, novel acetylcholinesterase and butyrylcholinesterase pseudo-irreversible inhibitors. Pejchal V; Štěpánková Š; Pejchalová M; Královec K; Havelek R; Růžičková Z; Ajani H; Lo R; Lepšík M Bioorg Med Chem; 2016 Apr; 24(7):1560-72. PubMed ID: 26947959 [TBL] [Abstract][Full Text] [Related]
36. Novel N-benzylpyridinium moiety linked to arylisoxazole derivatives as selective butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study. Vafadarnejad F; Karimpour-Razkenari E; Sameem B; Saeedi M; Firuzi O; Edraki N; Mahdavi M; Akbarzadeh T Bioorg Chem; 2019 Nov; 92():103192. PubMed ID: 31446239 [TBL] [Abstract][Full Text] [Related]
37. In silico, theoretical biointerface analysis and in vitro kinetic analysis of amine compounds interaction with acetylcholinesterase and butyrylcholinesterase. Kandasamy S; Loganathan C; Sakayanathan P; Karthikeyan S; Stephen AD; Marimuthu DK; Ravichandran S; Sivalingam V; Thayumanavan P Int J Biol Macromol; 2021 Aug; 185():750-760. PubMed ID: 34216669 [TBL] [Abstract][Full Text] [Related]
38. Synthesis, molecular modelling and biological evaluation of tetrasubstituted thiazoles towards cholinesterase enzymes and cytotoxicity studies. Mumtaz A; Shoaib M; Zaib S; Shah MS; Bhatti HA; Saeed A; Hussain I; Iqbal J Bioorg Chem; 2018 Aug; 78():141-148. PubMed ID: 29567428 [TBL] [Abstract][Full Text] [Related]
39. Design and discovery of Novel Thiazole acetamide derivatives as anticholinesterase agent for possible role in the management of Alzheimer's. Sun ZQ; Tu LX; Zhuo FJ; Liu SX Bioorg Med Chem Lett; 2016 Feb; 26(3):747-750. PubMed ID: 26783181 [TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and evaluation of new thiazole-piperazines as acetylcholinesterase inhibitors. Yurttaş L; Kaplancıklı ZA; Özkay Y J Enzyme Inhib Med Chem; 2013 Oct; 28(5):1040-7. PubMed ID: 22871134 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]